{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T04:19:50Z","timestamp":1785039590327,"version":"3.55.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>Chronic rejection is arguably the main obstacle to long-term graft survival. Yet, clinical trials focusing on this condition are disappointingly scarce. Significant advances in treating chronic rejection cannot happen if there is no conduit for testing novel therapies. Here, we identified the main hurdles holding back clinical trials for chronic rejection and outlined a series of actions to address these roadblocks. We suggest that a new strategic plan combining expertise in basic and clinical research and leveraging complementary resources be launched to specifically target chronic rejection and achieve long-awaited progress. We only need the will.<\/jats:p>","DOI":"10.1097\/tp.0000000000005081","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T05:00:55Z","timestamp":1735880455000},"page":"411-417","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Where Are All the Clinical Trials for Chronic Rejection?"],"prefix":"10.1097","volume":"109","author":[{"given":"Paolo","family":"Cravedi","sequence":"first","affiliation":[{"name":"Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Maggiore","sequence":"additional","affiliation":[{"name":"Nephrology Unit, University Hospital of Parma, Parma, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Molinari","sequence":"additional","affiliation":[{"name":"Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Levitsky","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Zorn","sequence":"additional","affiliation":[{"name":"Department of Medicine, Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"R1-20250219","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.trre.2013.01.001","article-title":"Global database on donation and transplantation: goals, methods and critical issues (https:\/\/www.transplant-observatory.org).","volume":"27","author":"Mahillo","year":"2013","journal-title":"Transplant Rev"},{"key":"R2-20250219","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.3389\/fimmu.2020.612576","article-title":"Transplantation of marginal organs\u2014immunological aspects and therapeutic perspectives.","volume":"11","author":"S\u00fcsal","year":"2020","journal-title":"Front Immunol"},{"key":"R3-20250219","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJMra2014530","article-title":"Long-term survival after kidney transplantation.","volume":"385","author":"Hariharan","year":"2021","journal-title":"N Engl J Med"},{"key":"R4-20250219","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1600-6143.2004.00515.x","article-title":"Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"R5-20250219","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/j.1600-6143.2011.03539.x","article-title":"Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success.","volume":"11","author":"Lodhi","year":"2011","journal-title":"Am J Transplant"},{"key":"R6-20250219","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.healun.2017.07.019","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report\u20142017; Focus Theme: Allograft ischemic time.","volume":"36","author":"Lund","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R7-20250219","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.healun.2014.08.004","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report\u20142014; focus theme: retransplantation.","volume":"33","author":"Yusen","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"R8-20250219","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1600-6143.2010.03312.x","article-title":"The histology of solitary renal allografts at 1 and 5 years after transplantation.","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"R9-20250219","first-page":"319","article-title":"Cardiac allograft vasculopathy: a review.","volume":"48","author":"Ramzy","year":"2005","journal-title":"Can J Surg"},{"key":"R10-20250219","article-title":"Zakim and Boyer\u2019s hepatology.","author":"Boyer","year":"2012","journal-title":"Zakim Boyer\u2019s Hepatol"},{"key":"R12-20250219","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1681\/ASN.2018111101","article-title":"Long-term outcomes after acute rejection in kidney transplant recipients: an ANZDATA analysis.","volume":"30","author":"Clayton","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"R13-20250219","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1432-2277.2000.tb01008.x","article-title":"Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients.","volume":"13","author":"Madden","year":"2000","journal-title":"Transpl Int"},{"key":"R14-20250219","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.transproceed.2004.10.070","article-title":"Early acute rejection does not affect chronic allograft nephropathy and death censored graft failure.","volume":"36","author":"He","year":"2004","journal-title":"Transplant Proc"},{"key":"R15-20250219","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1681\/ASN.2020071106","article-title":"A randomized clinical trial of anti-IL-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection.","volume":"32","author":"Doberer","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"R16-20250219","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-022-06198-9","article-title":"Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial.","volume":"23","author":"Mayer","year":"2022","journal-title":"Trials"},{"key":"R17-20250219","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/ajt.14001","article-title":"Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Pilot Randomized Controlled Trial.","volume":"17","author":"Kulkarni","year":"2017","journal-title":"Am J Transplant"},{"key":"R18-20250219","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/ajt.14228","article-title":"Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients.","volume":"17","author":"Choi","year":"2017","journal-title":"Am J Transplant"},{"key":"R19-20250219","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/ajt.14520","article-title":"Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial.","volume":"18","author":"Moreso","year":"2018","journal-title":"Am J Transplant"},{"key":"R20-20250219","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1681\/ASN.2017070818","article-title":"A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection.","volume":"29","author":"Eskandary","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R21-20250219","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/thoraxjnl-2014-205998","article-title":"A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation.","volume":"70","author":"Corris","year":"2015","journal-title":"Thorax"},{"key":"R22-20250219","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/sctm.16-0372","article-title":"Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First-in-Man Study.","volume":"6","author":"Chambers","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"R23-20250219","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193564","article-title":"Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.","volume":"13","author":"Ruttens","year":"2018","journal-title":"PLoS One"},{"key":"R24-20250219","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00167-2019","article-title":"A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation.","volume":"5","author":"Iacono","year":"2019","journal-title":"ERJ Open Res"},{"key":"R25-20250219","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2019-000465","article-title":"Long-term effect of azithromycin in bronchiolitis obliterans syndrome.","volume":"6","author":"Gan","year":"2019","journal-title":"BMJ Open Respir Res"},{"key":"R26-20250219","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/stcltm\/szac051","article-title":"Feasibility and safety of low-dose mesenchymal stem cell infusion in lung transplant recipients.","volume":"11","author":"Erasmus","year":"2022","journal-title":"Stem Cells Transl. Med"},{"key":"R27-20250219","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.661643","article-title":"Tackling chronic kidney transplant rejection: challenges and promises.","volume":"12","author":"Lai","year":"2021","journal-title":"Front Immunol"},{"key":"R28-20250219","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1111\/j.1600-6143.2011.03677.x","article-title":"Surveillance protocol kidney transplant biopsies: their evolving role in clinical practice.","volume":"11","author":"Henderson","year":"2011","journal-title":"Am J Transplant"},{"key":"R29-20250219","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0037-1615290","article-title":"New targets for the prevention of chronic rejection after thoracic organ transplantation.","volume":"66","author":"Heim","year":"2018","journal-title":"Thorac Cardiovasc Surg"},{"key":"R30-20250219","doi-asserted-by":"crossref","first-page":"7771","DOI":"10.3748\/wjg.v27.i45.7771","article-title":"Chronic rejection after liver transplantation: opening the Pandora\u2019s box.","volume":"27","author":"Angelico","year":"2021","journal-title":"World J Gastroenterol"},{"key":"R31-20250219","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1681\/ASN.0000000000000260","article-title":"Prognostic biomarkers in kidney transplantation: a systematic review and critical appraisal.","volume":"35","author":"Raynaud","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"R32-20250219","first-page":"89","article-title":"Measured GFR by Utilizing Population Pharmacokinetic Methods to Determine Iohexol Clearance.","author":"\u00c5sberg","year":"2019","journal-title":"Kidney Int Rep"},{"key":"R33-20250219","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2018020160","article-title":"A Novel Method for Rapid Bedside Measurement of GFR.","volume":"29","author":"Rizk","year":"2018","journal-title":"Journal of the American Society of Nephrology : JASN"},{"key":"R37-20250219","doi-asserted-by":"crossref","first-page":"10142","DOI":"10.3389\/ti.2021.10142","article-title":"Redefining risk stratification and endpoints for clinical trials in kidney transplantation: rationale and methodology of proposals submitted to the European Medicines Agency by the European Society for Organ Transplantation.","volume":"35","author":"Naesens","year":"2022","journal-title":"Transpl Int"},{"key":"R38-20250219","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.","volume":"28","author":"Voors","year":"2022","journal-title":"Nat Med"},{"key":"R39-20250219","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/eurheartj\/ehr352","article-title":"The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities.","volume":"33","author":"Pocock","year":"2012","journal-title":"Eur Heart J"},{"key":"R40-20250219","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1681\/ASN.0000000000000243","article-title":"Development and validation of a new hierarchical composite end point for clinical trials of kidney disease progression.","volume":"34","author":"Heerspink","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"R41-20250219","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1111\/bcp.15870","article-title":"Clinical performance of volumetric finger-prick sampling for the monitoring of tacrolimus, creatinine and haemoglobin in kidney transplant recipients.","volume":"89","author":"Vethe","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"R42-20250219","doi-asserted-by":"crossref","first-page":"786","DOI":"10.5858\/arpa.2021-0533-OA","article-title":"Application of a fully automated dried blood spot method for therapeutic drug monitoring of immunosuppressants: another step toward implementation of dried blood spot analysis.","volume":"147","author":"Deprez","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"R43-20250219","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/FTD.0000000000000697","article-title":"Tacrolimus area under the concentration versus time curve monitoring, using home-based volumetric absorptive capillary microsampling.","volume":"42","author":"Gustavsen","year":"2020","journal-title":"Ther Drug Monit"},{"key":"R44-20250219","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/FTD.0000000000001083","article-title":"Applications of volumetric absorptive microsampling technique: a systematic critical review.","volume":"45","author":"Dodeja","year":"2023","journal-title":"Ther Drug Monit"},{"key":"R45-20250219","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/ckj\/sfac017","article-title":"Detecting, preventing and treating non-adherence to immunosuppression after kidney transplantation.","volume":"15","author":"Gandolfini","year":"2022","journal-title":"Clin Kidney J"},{"key":"R46-20250219","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"Treg cell-based therapies: challenges and perspectives.","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"R47-20250219","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2215\/CJN.01140113","article-title":"Fostering innovation, advancing patient safety: the kidney health initiative.","volume":"8","author":"Archdeacon","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R48-20250219","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1081\/BIP-200062277","article-title":"Statistical consideration of adaptive methods in clinical development.","volume":"15","author":"Chow","year":"2005","journal-title":"J Biopharm Stat"},{"key":"R49-20250219","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10543400600609718","article-title":"Adaptive design in clinical research: issues, opportunities, and recommendations.","volume":"16","author":"Chang","year":"2006","journal-title":"J Biopharm Stat"},{"key":"R50-20250219","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12874-022-01603-y","article-title":"Improving clinical trials using Bayesian adaptive designs: a breast cancer example.","volume":"22","author":"Hong","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"R51-20250219","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/ajt.16311","article-title":"A noninferiority design for a delayed calcineurin inhibitor substitution trial in kidney transplantation.","volume":"21","author":"Nickerson","year":"2021","journal-title":"Am J Transplant"},{"key":"R52-20250219","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2147\/JMDH.S299765","article-title":"Seeing the Elephant: a systematic scoping review and comparison of patient-centeredness conceptualizations from three seminal perspectives.","volume":"14","author":"Olson","year":"2021","journal-title":"J Multidiscip Healthc"},{"key":"R53-20250219","doi-asserted-by":"crossref","first-page":"e064347","DOI":"10.1136\/bmjopen-2022-064347","article-title":"Self-management in adults after solid-organ transplantation: a scoping review protocol.","volume":"13","author":"Jobst","year":"2023","journal-title":"BMJ Open"},{"key":"R54-20250219","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.ajkd.2015.07.030","article-title":"Motivations, challenges, and attitudes to self-management in kidney transplant recipients: a systematic review of qualitative studies.","volume":"67","author":"Jamieson","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R55-20250219","doi-asserted-by":"crossref","first-page":"10134","DOI":"10.3389\/ti.2022.10134","article-title":"Patient-reported outcomes as endpoints in clinical trials of kidney transplantation interventions.","volume":"35","author":"Tong","year":"2022","journal-title":"Transpl Int"},{"key":"R56-20250219","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/TP.0000000000002125","article-title":"Establishing a core outcome measure for graft health: a Standardized Outcomes in Nephrology-Kidney Transplantation (SONG-Tx) Consensus Workshop Report.","volume":"102","author":"Tong","year":"2018","journal-title":"Transplantation"},{"key":"R57-20250219","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.kint.2023.07.013","article-title":"Using causal directed acyclic graphs (DAGs) to select patient-important outcomes in transplantation trials-interventions to treat polyomavirus infection as an example.","volume":"104","author":"Wu","year":"2023","journal-title":"Kidney Int"},{"key":"R58-20250219","first-page":"15197","article-title":"Medicare program; hospital conditions of participation: requirements for approval and re-approval of transplant centers to perform organ transplants. Final rule.","volume":"72","year":"2007","journal-title":"Fed Regist"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:01:59Z","timestamp":1739959319000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005081","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]}}}